As the number of surgical procedures performed annually in the developed world increases, clinicians and healthcare decision makers are showing an increased interest in new methods for closing and sealing surgical wounds.
This post is an original post by ScienceDaily: Skin Care News
Posted: May 14th, 2008 under skin health.
Comments: none
Acne is one of the most common skin disorders in both males and females, occurring on the chest, face, shoulders and back. Almost everyone between the age of puberty and adulthood experiences acne. Because of the prevalence of acne, many people search for an acne treatment, often for various reasons.
This post is an original post by ScienceDaily: Skin Care News
Posted: May 14th, 2008 under skin health.
Comments: none
Acne vulgaris is the medical term for common acne. Acne is widespread among teenagers, although a smaller percentage of adults in their 30’s and 40’s still get acne. Common acne is characterized by the presence of one or all of the following: whiteheads, blackheads, papules, pustule or pimples that are seen on the face, chest, back, shoulders, even neck. Thousands of oil glands can be found in the skin.
This post is an original post by ScienceDaily: Skin Care News
Posted: May 14th, 2008 under skin health.
Comments: none
Warner Chilcott and LEO Pharma announced that the United States Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Taclonex Scalp(R) (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Topical Suspension. LEO Pharma submitted the NDA for Taclonex Scalp(R) to the FDA in July 2007. Taclonex Scalp(R) is a topical suspension containing a combination of calcipotriene 0.005% and betamethasone dipropionate 0.
This post is an original post by ScienceDaily: Skin Care News
Posted: May 14th, 2008 under skin health.
Comments: none
